Merus announces re-election of directors

TORONTO, March 30, 2016 /CNW/ - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] reported today the results of its 2016 annual general meeting of shareholders held on March 30, 2016.

All directors nominated as listed in the Company's management information circular dated February 26, 2016 were re-elected as members of the board as follows:

Director

Votes For

% For

Withheld Votes

%

Michael Cloutier

48,379,697

98.28%

848,566

1.72%

Robert S. Pollock

47,798,438

97.10%

1,429,825

2.90%

Timothy G. Sorensen

47,797,737

97.09%

1,430,526

2.91%

David D. Guebert

47,796,057

97.09%

1,432,206

2.91%

Theresa Firestone

47,598,927

96.69%

1,629,336

3.31%

Barry Fishman

48,401,638

98.32%

826,625

1.68%

Robert Bloch

49,146,998

99.83%

81,265

0.17%

In addition, shareholders approved the appointment of MNP LLP,
Chartered Accountants, as the auditor of Merus to hold office until the next annual meeting of shareholders.

About Merus Labs

Merus Labs is a specialty pharmaceutical company focused on acquiring established products. The Company leverages its expertise and commercial platform in Europe, Canada and select other markets to deliver value.

SOURCE Merus Labs International Inc.

For further information: Phone: (416) 593-3725, Email: info@meruslabs.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890